Luca M. Zaeck

Capacity building for genomic surveillance of mpox and other emerging diseases in resource-limited settings within the African Great Lakes region.

Journal: Communications medicine

Published: November 25, 2025

Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.

Journal: The Journal of infection

Published: November 20, 2025

COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination.

Journal: Npj viruses

Published: August 29, 2025

High-throughput multiplex immunoassay for the detection of mpox and MVA-BN vaccination up to 2 years after exposure in Belgium: a retrospective diagnostic accuracy study.

Journal: The Lancet. Microbe

Published: June 18, 2025

Metagenomic sequencing of mpox virus clade Ib lesions identifies possible bacterial and viral co-infections in hospitalized patients in eastern DRC.

Journal: Microbiology spectrum

Published: May 30, 2025

Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study.

Journal: The Lancet. Infectious diseases

Published: May 25, 2025

Serological evidence of clade Ib Mpox transmission by sex workers and within household in South Kivu, DRC.

Journal: Nature communications

Published: May 23, 2025

AI-driven discovery of antiretroviral drug bictegravir and etravirine as inhibitors against monkeypox and related poxviruses.

Journal: Communications biology

Published: April 14, 2025

Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 05, 2024

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: September 20, 2024

Profiling the SARS-CoV-2-specific T-cell response.

Journal: The Lancet. Infectious diseases

Published: May 31, 2024

Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants.

Journal: The Journal of infection

Published: May 15, 2024

Capacity building for genomic surveillance of mpox and other emerging diseases in resource-limited settings within the African Great Lakes region.

Capacity building for genomic surveillance of mpox and other emerging diseases in resource-limited settings within the African Great Lakes region.

Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.

Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.

COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination.

COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination.

High-throughput multiplex immunoassay for the detection of mpox and MVA-BN vaccination up to 2 years after exposure in Belgium: a retrospective diagnostic accuracy study.

High-throughput multiplex immunoassay for the detection of mpox and MVA-BN vaccination up to 2 years after exposure in Belgium: a retrospective diagnostic accuracy study.

Metagenomic sequencing of mpox virus clade Ib lesions identifies possible bacterial and viral co-infections in hospitalized patients in eastern DRC.

Metagenomic sequencing of mpox virus clade Ib lesions identifies possible bacterial and viral co-infections in hospitalized patients in eastern DRC.

Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study.

Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study.

Serological evidence of clade Ib Mpox transmission by sex workers and within household in South Kivu, DRC.

Serological evidence of clade Ib Mpox transmission by sex workers and within household in South Kivu, DRC.

AI-driven discovery of antiretroviral drug bictegravir and etravirine as inhibitors against monkeypox and related poxviruses.

AI-driven discovery of antiretroviral drug bictegravir and etravirine as inhibitors against monkeypox and related poxviruses.

Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.

Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.

Profiling the SARS-CoV-2-specific T-cell response.

Profiling the SARS-CoV-2-specific T-cell response.

Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants.

Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants.

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.